IFNA12P

Across TCGA pan-cancer cohorts, IFNA12P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated IFNA12P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher IFNA12P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IFNA12P expression acts as an unfavorable survival marker.

PAAD, READ, and UCEC are the cancer types where IFNA12P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.141	0.490	<.001	90	view →
READ	DFS	Tertile	All	0.027	0.845	<.001	72	view →
UCEC	DFS	Tertile	III,IV	0.095	0.595	.005	72	view →
HNSC	DFS	Tertile	All	0.473	0.701	.013	48	view →
LAML	DFS	Tertile	All	0.223	0.581	.019	36	view →
LUSC	OS	Tertile	II,III,IV	0.420	0.735	.005	27	view →
THCA	DFS	Tertile	III,IV	0.188	0.779	<.001	24	view →
STAD	DFS	Tertile	All	0.483	0.670	.009	18	view →
MESO	OS	Tertile	All	0.226	0.566	.017	18	view →
PRAD	OS	Tertile	All	0.858	0.990	<.001	18	view →
KIRP	OS	Tertile	All	0.412	0.723	.003	18	view →
GBM	OS	Tertile	All	0.305	0.442	.015	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

IFNA12P–PAAD (DFS)

Open the PAAD breakdown →